Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Juvederm Users: Cosmetic Dermatologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
Sunil DhawanJuly 7, 2008
New uses for old meds- benefit or drawback?
Analysis of: One drug, many uses. Good idea? | www.indystar.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...
Sunil DhawanJuly 2, 2008
Evolence Approval- what effect will it have on the filler market
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...
July 2, 2008
Concerns about Evolence being successful.
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
Here are the concerns.1. The collagen injections by Collagen Corp could not compete with hyaluronic acid because it typically does not last longer.  Typically, collagen does not last as long in certain facial regions.2.  There are structural changes that would have to be done on collagen to...
Sunil DhawanJune 27, 2008
Adolesecnt acne treatable
Analysis of: What Skin Care Routines and Treatments Are Effective for Adolescent Acne? | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that, for the most part , it describes a basic therapeutic regimen for adolescent acne patients. The only error is describing the inflamed lesions as "infections." Acne is predominantly an inflammatory condition, not an infectious one, though a bacteria is involved...
Adam SchaffnerJune 26, 2008
Allergan and Aczone: Likely a Winning Combination
Analysis of: Allergan Aquisition of Aczone | agn360.client.shareholder.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
Allergan has a strong infrastructure to support dermatologic and aesthetic products.  Aczone, an aqueous topical gel containing 5% dapsone, will be a new product which will help treat patients with acne.  "The strength of topical dapsone gel appears to be its high efficacy against...
Adam SchaffnerJune 26, 2008
Obesity: Higher Healthcare Costs, Lower Productivity
Analysis of: Obesity costs employers $45 bil a year | www.nytimes.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
There is no revelation in stating that obese people move slower or have more health problems compared to skinny people.  High blood pressure and diabetes are commonly associated with obesity.  Morbidly obese people may have difficulty sitting in a single coach airplane seat, fitting through...
Sunil DhawanJune 25, 2008
Allergan's acquisition of Aczone- is this significant?
Analysis of: Allergan Aquisition of Aczone | agn360.client.shareholder.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that this acquisition is the first new product for Allergan's dermatology division in several years. This is also the first novel molecule in 5-7 years that has been released. The issues of having to get blood tests with this topical agent have been solved. The obvious paring...
Adam SchaffnerJune 23, 2008
Hair Removal: An Expanding Market
Analysis of: Zapping Teenage Torment | www.nytimes.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
Hair used to be something we all accepted.  Now, unwanted hair is viewed as unacceptable.  The market for hair removal is almost endless.  Men want hair removed from the nostrils, neck, back, and chest.  Women want hair removed from the upper lip, chin, sideburns, arms, legs,...
Adam SchaffnerJune 23, 2008
Improving the "Tired Look" - How to Treat Dark Circles Under Eyes
Analysis of: Putting ‘You Look Tired’ to Rest | www.nytimes.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
Looking rested and refreshed is big business.  Dark circles can make one appear tired and old - even at the young age of 25.  Therefore, some people will stop at nothing to conceal these circles.  53% of 13,000 Clinique users cited dark under-eye circles and puffiness as their number...
Adam SchaffnerJune 23, 2008
Saying "I'm Sorry" Will Decrease Medical Malpractice Premiums and Increase the Quality of Care
Analysis of: Doctors Say ‘I’m Sorry’ Before ‘See You in Court’ | www.nytimes.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
For years, doctors have been taught to deny medical errors and defend themselves to the end.  Such denial is contrary to the honesty doctors and patients desire in a patient-physician relationship.  However, the risk of medical malpractice has led physicians to pursue this practice. ...

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 Next11 to 20 of 188

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773